Cargando…
From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards
BACKGROUND: A comprehensive understanding of cancer has been furthered with technological improvements and decreasing costs of next-generation sequencing (NGS). However, the complexity of interpreting genomic data is hindering the implementation of high-throughput technologies in the clinical contex...
Autores principales: | Perera-Bel, Júlia, Hutter, Barbara, Heining, Christoph, Bleckmann, Annalen, Fröhlich, Martina, Fröhling, Stefan, Glimm, Hanno, Brors, Benedikt, Beißbarth, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856211/ https://www.ncbi.nlm.nih.gov/pubmed/29544535 http://dx.doi.org/10.1186/s13073-018-0529-2 |
Ejemplares similares
-
Community-driven development of a modified progression-free survival ratio for precision oncology
por: Mock, Andreas, et al.
Publicado: (2019) -
Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls
por: Horak, Peter, et al.
Publicado: (2016) -
Explaining decisions of graph convolutional neural networks: patient-specific molecular subnetworks responsible for metastasis prediction in breast cancer
por: Chereda, Hryhorii, et al.
Publicado: (2021) -
Detection of Simultaneous Group Effects in MicroRNA Expression and Related Target Gene Sets
por: Artmann, Stephan, et al.
Publicado: (2012) -
Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with PDL1 amplification
por: Gröschel, Stefan, et al.
Publicado: (2016)